CONFIDENTIAL—DO NOT DISTRIBUTE

First Page		Document Content
Date: 2014-10-31 18:17:26 Alkenes Axitinib Benzamides Pyridines Thioethers Renal cell carcinoma Treatment and prognosis of renal cell carcinoma Pfizer Vascular endothelial growth factor Medicine Kidney cancer Chemistry		CONFIDENTIAL—DO NOT DISTRIBUTE Add to Reading List Source URL: sfj-pharma.com Download Document from Source Website File Size: 362,19 KB Share Document on Facebook

	Votrient® (pazopanib) Core communications DocID: 1a5n0 - View Document
	467 VERIFICATION OF A FUNCTIONALIZED STRUCTURED MEDICAL WIRE FOR THE ISOLATION OF CIRCULATING TUMOR CELLS (CTC) IN PATIENTS WITH RENAL CELL CARCINOMA DocID: 19GO3 - View Document
	Cytoreductive nephrectomy for metastatic disease in 2014: Are we any wiser now ? Axel Bex The Netherlands Cancer Institute Amsterdam, The Netherlands DocID: 19aSe - View Document
	Microsoft WordSorafenib NEXAVAR BayerPSD FINAL.doc DocID: 18slu - View Document
	7.2 AXITINIB tablets, 1 mg & 5 mg; Inlyta®; Pfizer Australia Pty Ltd. Provisionally redacted Public Summary Document: Some of the content redacted from this PSD is still the subject of discussion between the Department DocID: 17Ht9 - View Document